Kevin Lindquist is an experienced researcher and core lab manager currently serving as the Executive Director of Protein Engineering at Eli Lilly and Company. With a robust background in the pharmaceuticals industry, they began their career at Pfizer, contributing to various biologics drug discovery projects and managing a biosensor lab. Kevin has expertise in antibody-based technologies and has played a pivotal role in developing and automating data analysis for high-throughput antibody screening. Previously, they held positions at Biacore and Alnis Biosciences, and they earned their Master of Science at the University at Buffalo, focusing on protein-surface binding in biosensor devices.
This person is not in the org chart
This person is not in any teams
This person is not in any offices